People · Operator
Named in public records as an officer, director or promoter · active 2017–2025 · Biotechnology, Pharmaceuticals, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Surrozen, Inc./DE | — | Biotechnology | Series D+ | $269.4M | $657.8M | 2024 |
| vTv Therapeutics Inc. | — | Pharmaceuticals | Series C | $80.5M | $501.8M | 2017 |
| Surrozen, Inc. | — | Biotechnology | Series C | $50.0M | $2.0B | 2020 |
| SafeIdentity Holdings, Inc. | — | Other Technology | Series B | $17.7M | $105.0M | 2025 |
| Navidence, Inc. | — | Other Technology | Seed | $3.0M | $7.7M | 2025 |
Craig Parker at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Craig Parker on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Paul Meister | 1 | 12 |
| David Goeddel | 1 | 10 |
| Christopher Stone | 1 | 8 |
| Tim Kutzkey | 1 | 7 |
| Steven Cohen | 1 | 6 |
| JAMES HILL | 1 | 6 |
| Daniel O'Connor | 1 | 5 |
| John Fry | 1 | 4 |
| Sebastian Anastassiou | 1 | 3 |
| Tam Hulusi | 1 | 3 |
| Jeffrey Kindler | 1 | 3 |
| Howard Weiner | 1 | 3 |
| Paul Savas | 1 | 2 |
| Richard L Nelson | 1 | 2 |
| Paul J. Sekhri | 1 | 2 |
| Noel Spiegel | 1 | 2 |
| Travis Deyle | 1 | 2 |
| Jason Hart | 1 | 2 |
| Rudy Howard | 1 | 2 |
| Charles Williams | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.